(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. SULF1 and SULF2 regulate GDNF binding to heparin and the GDNF signaling
activity. (A) SULF1 reduces GDNF binding to heparin. Heparin
conjugated to agarose beads was digested by SULF1 or inactive QSULF1(C-A)
control. Various amounts of GDNF were incubated with enzyme-digested heparin
beads (20 µl) to allow binding. The amount of GDNF bound to the beads was
assayed by western blot. The intensity of individual bands was quantified by
Multi-analysis software (Bio-Rad). Numbers listed beneath each lane are
normalized quantification of the individual bands from three independent
experiments. (B) SULF1 has no effect on GDNF binding to GFR
1.
Heparin predigested either by SULF1 or inactive QSULF1(C-A) was added to a
mixture of GDNF (10 ng) and GFR
1-Fc (1 µg) to allow
GDNF-heparin-GFR
1-Fc ternary complex formation. The complex was pulled
down by protein A-agarose beads. The amount of GDNF bound to GFR
1 was
assayed by western blot and normalized to the amount of GFR
1.
(C-E) SULF2 enhances the GDNF signaling activity. NG108-15 cells that
were stably transfected with the control vector or the SULF2 expression vector
were stimulated by GDNF for 5 minutes, or by GDNF (5 ng/ml) for various
lengths of time. The activation of GDNF signaling pathway was analyzed by
assaying the phosphorylation of RET (at tyrosine, p-RET) and of the downstream
AKT (p-AKT) by western blot. Total RET or Erks were used as loading control.
Data shown are controlled for loading and then normalized to the basal level
of control cells. (F) SULF2 had no effect on NGF signaling in PC12
cells. Serum-starved PC12 cells that stably expressed SULF2 or inactive
QSULF1(C-A) were treated with NGF. The activation of NGF signaling was
analyzed by assaying the phosphorylation of downstream Erks (p-Erk). Data
presented are the mean and standard deviation of a minimum of three
independent experiments. **, P<0.01, *
P<0.05 (two-tailed Student's t-test). (G)
Sulf double-mutant esophagi have reduced MAPK phosphorylation in the
intrinsic neurons. E14.5 esophageal sections were immunostained with an
antibody against phosphorylated MAPK. Arrowheads point to phosphorylated MAPK
immunoreactivity in neuronal cell bodies within the muscle layers. Asterisks
mark the endothelial cells with phosphorylated MAPK immunoreactivity.